MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Biosimilars and Bioanalytical Methods
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

876 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
876 works in the cohort · of 4,299,418page 16 of 18

Labels cover 4 of 876 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 876 of 876 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

aboutno affunlabeled
Monitorización farmacocinética de anticuerpos monoclonales
2016· dissertation· es· Deposito de Investigacion Universidad de Sevilla (University of Seville)· Immunology and Microbiology
distilled prediction:candidate · metaepi_narrow+research_integrityconsensus · none
0
citations
affunlabeled
A Comparative Parallel Study of Pharmacokinetics and Immunogenicity Following Single Intravenous Administration of Bevacizumab Biosimilar RPH-001 (Manufactured by R-Pharm Group, Russia) and Avastin® (Manufactured by F. Hoffmann-La Roche Ltd., Switzerland) in Healthy Male Volunteers
М. А. Колганова, N. S. Bagaevа, Y. V. Medvedev, I. E. Shohin, A. V. Demchinskaya, Т. Н. Палкина +6 more
2019· article· en· Drug development & registration· Immunology and Microbiology
distilled prediction:candidate · metaepi_narrowconsensus · none
0
citations
afffundaboutunlabeled
Drug Discontinuation and Persistent Symptoms Among Initiators of Bio-Originator and Biosimilar Anti–tumor Necrosis Factor Drugs in Inflammatory Bowel Disease: Real-world Contemporary Data From the CAnadian Network for Advanced Interdisciplinary Methods/CIRC Registry
Banke Oketola, Sasha Bernatsky, Luck Lukusa, Cristiano Soares de Moura, Autumn Neville, Yvette Leung +5 more
2025· article· en· Gastro Hep Advances· Immunology and Microbiology
distilled prediction:candidate · noneconsensus · none
0
citations
affunlabeled
Editorial: antigenic response to <scp>CT</scp>‐P13 and infliximab originator in <scp>IBD</scp> shows similar epitope recognition—evidence from basic science supports safe switching to biosimilars. Authors’ reply
João Gonçalves, Fernando Magro, Silvio Danese, Péter L. Lakatos, Shomron Ben‐Horin
2018· editorial· en· Alimentary Pharmacology & Therapeutics· Immunology and Microbiology
distilled prediction:candidate · metaepi_narrow+research_integrityconsensus · metaepi_narrow+research_integrity
0
citations
aboutno affunlabeled
Regulatory Overview of Biosimilars: Current Scenario and Future Opportunities
Ajmer Singh Grewal, Viney Lather, Shashikant Bhardwaj, Deepti Pandita
2015· article· en· Applied Clinical Research Clinical Trials and Regulatory Affairs· Immunology and Microbiology
distilled prediction:candidate · metaresearch+metaepi_narrow+sts+research_integrityconsensus · metaresearch+research_integrity
0
citations
aboutno affunlabeled
Global Standards for Biosimilars v1
Bella Smith
2018· preprint· en· Immunology and Microbiology
distilled prediction:candidate · metaepi_narrow+research_integrity+insufficient_payloadconsensus · none
0
citations
affunlabeled
Early model-based precision-dosing at home to guide adalimumab therapy
Paul de Klaver, Ron J. Keizer, Rob ter Heine, Frank Hoentjen, Paul J. Boekema, Inge Kuntzel +6 more
2024· preprint· en· Immunology and Microbiology
distilled prediction:candidate · metaepi_narrow+research_integrity+insufficient_payloadconsensus · insufficient_payload
0
citations
aboutno affunlabeled
Equity valuation : WestJet Airlines
2019· dissertation· en· Repositório Institucional da Universidade Católica Portuguesa (Universidade Católica Portuguesa)· Immunology and Microbiology
distilled prediction:candidate · metaepi_narrow+research_integrity+insufficient_payloadconsensus · metaepi_narrow+research_integrity+insufficient_payload
0
citations
affno abstractunlabeled
Correction to: PANLAR consensus statement on biosimilars
Sérgio Cândido Kowalski, J. A. Benavides, Padilla Beltrán, Claudio Galarza-Maldonado, Carlo V. Caballero‐Uribe, Enrique R. Soriano +25 more
2019· erratum· en· Clinical Rheumatology· Immunology and Microbiology
distilled prediction:candidate · metaepi_narrow+research_integrity+insufficient_payloadconsensus · research_integrity+insufficient_payload
0
citations
affunlabeled
Biomarker World Congress 2005.
Pollen Yeung
2005· article· en· PubMed· Immunology and Microbiology
distilled prediction:candidate · insufficient_payloadconsensus · none
0
citations
venueno affno abstractunlabeled
10.1016/s1541-9800(10)70628-1
2000· article· en· Time to knit· Immunology and Microbiology
distilled prediction:candidate · insufficient_payloadconsensus · insufficient_payload
0
citations
← previousnext →

How this was built: Screen · Findings · About